Détail d'une personne de l'annuaire - fr | Cancéropôle Est, la recherche innovante dans la lutte contre le cancer

Management of Graves' ophthalmopathy by radiotherapy: A literature review.

Beige A, Boustani J, Bouillet B, Truc G

Cancer Radiother. 2024 06 20;:

Targeting two radiation-induced immunosuppressive pathways to improve the efficacy of normofractionated radiation therapy in a preclinical colorectal cancer model.

Boustani J, Lecoester B, Baude J, Latour C, Limagne E, Ladjohoulou R, Morgand V, Froidurot L, Ghiringhelli F, Truc G, Adotévi O, Mirjolet C

Int J Radiat Biol. 2024 03 20;:1-10

A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer.

Roussot N, Fumet JD, Limagne E, Thibaudin M, Hervieu A, Hennequin A, Zanetta S, Dalens L, Fourrier T, Galland L, Jacob P, Bertaut A, Rederstorff E, Chevalier C, Ghirardi S, Gilbert E, Khoukaz A, Martin E, Nicolet C, Quivrin M, Thibouw D, Vulquin N, Truc G, Rouffiac M, Ghiringhelli F, Mirjolet C

BMC Cancer. 2023 11 9;23(1):1080

Respective roles of surgery, chemotherapy and radiotherapy for recurrent pediatric and adolescent ependymoma: a national multicentric study.

Desrousseaux J, Claude L, Chaltiel L, Tensaouti F, Padovani L, Bolle S, Escande A, Alapetite C, Supiot S, Bernier-Chastagner V, Huchet A, Leseur J, Truc G, Leblond P, Bertozzi AI, Ducassou A, Laprie A

Int J Radiat Oncol Biol Phys. 2023 07 10;:

Randomized phase III trial of metabolic imaging-guided dose escalation of radio-chemotherapy in patients with newly diagnosed glioblastoma (SPECTRO GLIO trial).

Laprie A, Noel G, Chaltiel L, Truc G, Sunyach MP, Charissoux M, Magne N, Auberdiac P, Biau J, Ken S, Tensaouti F, Khalifa J, Sidibe I, Roux FE, Vieillevigne L, Catalaa I, Boetto S, Emmanuelle UC, Supiot S, Bernier V, Filleron T, Mounier M, Poublanc M, Olivier P, Delord JP, Cohen-Jonathan-Moyal E

Neuro Oncol. 2023 07 7;:

Is pre-radiotherapy metabolic heterogeneity of glioblastoma predictive of progression-free survival?

Tensaouti F, Desmoulin F, Gilhodes J, Roques M, Ken S, Lotterie JA, Noël G, Truc G, Sunyach MP, Charissoux M, Magné N, Lubrano V, Péran P, Cohen-Jonathan Moyal E, Laprie A

Radiother Oncol. 2023 04 4;:109665

Pseudoprogression versus true progression in patients with glioblastoma: A multiapproach analysis.

Sidibe I, Tensaouti F, Gilhodes J, Cabarrou B, Filleron T, Desmoulin F, Ken S, Noël G, Truc G, Sunyach M, Charissoux M, Magné N, Lotterie JA, Roques M, Péran P, Cohen-Jonathan Moyal E, Laprie A

Radiother Oncol. 2023 01 24;:109486

Efficacy of Chemotherapy Plus Bevacizumab in Recurrent Glioblastoma Multiform: A Real-life Study.

Beige A, Ghiringhelli F, Lecuelle J, Truntzer C, Truc G, Vincent J, Farah W, Borsotti F, Mazilu I, Ilie SM

Anticancer Res. 2022 12;42(12):5847-5858

[National meetings for complex cases in pediatric radiation oncology: Back on 6 years experience].

Tanguy R, Alapetite C, Laprie A, Vigneron C, Bolle S, Wellmant J, Huchet A, Stefan D, Potet H, Bernier V, Jouglar E, Escande A, Murraciole X, Leseur J, Truc G, Chapet S, Pasteris C, Bondiau PY, Claude L,

Bull Cancer. 2022 08 5;:

Treatment related factors associated with the risk of breast radio-induced-sarcoma.

Mirjolet C, Diallo I, Bertaut A, Veres C, Sargos P, Helfre S, Sunyach MP, Truc G, Le Pechoux C, Paumier A, Ducassou A, Jolnerovski M, Thariat J, Lapeyre M, Cordoba A, Mahé MA, Maingon P

Radiother Oncol. 2022 Apr 8;:

Quality control of 3D MRSI data in glioblastoma: Can we do without the experts?

Tensaouti F, Desmoulin F, Gilhodes J, Martin E, Ken S, Lotterie JA, Noël G, Truc G, Sunyach MP, Charissoux M, Magné N, Lubrano V, Péran P, Cohen-Jonathan Moyal E, Laprie A

Magn Reson Med. 2021 Nov 26;:

Anti-PD-1/Anti-PD-L1 Drugs and Radiation Therapy: Combinations and Optimization Strategies.

Boustani J, Lecoester B, Baude J, Latour C, Adotevi O, Mirjolet C, Truc G

Cancers (Basel). 2021 Sep 29;13(19):

[Role of radiotherapy in haematology].

Peignaux-Casasnovas K, Truc G, Rossi C, Casasnovas O

Cancer Radiother. 2021 Aug 28;:

[Abscopal effect: Myth or reality?]

Mirjolet C, Truc G

Cancer Radiother. 2021 Aug 27;:

[Extreme hypofractionated radiation therapy for pancreatic cancer].

Rouffiac M, Ghirardi S, Chevalier C, Bessières I, Peignaux-Casasnovas K, Truc G, Créhange G

Cancer Radiother. 2021 Jul 17;:

High risk of recurrence for grade II meningioma: a 10-year multicenter analysis of prognosis factors.

Bender L, Somme F, Lhermitte B, Ahle G, Boone M, Blonski M, Pouget C, Truc G, Cebula H, Noël G

Chin Clin Oncol. 2021 Mar 10;:

[Multidisciplinary team meeting in supportive care: 12 years of experience in a French comprehensive cancer center].

Favier L, Bremaud N, Tharin Z, Blanc J, Bertaut A, Alavoine V, Dubief A, Truc G, Dorlean C, Coudert B

Bull Cancer. 2020 Sep 21;:

[Seeking colleagues' advice when facing complex clinical situations].

Blanchard P, Peiffert D, Truc G

Cancer Radiother. 2020 Aug 19;:

Exclusive Hyper-fractionated Radiotherapy and reduced boost volume for standard-risk medulloblastoma: pooled analysis of the two French multicentric studies MSFOP98 and MSFOP 2007 and correlation with molecular subgroups.

Carrie C, Kieffer V, Figarella-Branger D, Masliah-Planchon J, Bolle S, Bernier V, Laprie A, Supiot S, Leseur J, Habrand JL, Alapetite C, Kerr C, Dufour C, Claude L, Chapet S, Huchet A, Bondiau PY, Escande A, Truc G, Nguyen TD, Pasteuris C, Vigneron C, Muracciole X, Bourdeaut F, Appay R, Dubray B, Colin C, Ferlay C, Dussart S, Chabaud S, Padovani L,

Int. J. Radiat. Oncol. Biol. Phys.. 2020 Aug 5;:

Long-term response to Olaparib in carcinomatous meningitis of a mutated ovarian cancer: A case report.

Favier L, Truc G, Boidot R, Bengrine-Lefevre L

Mol Clin Oncol. 2020 Jul;13(1):73-75

RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort study.

Mirjolet C, Merlin JL, Truc G, Noël G, Thariat J, Domont J, Sargos P, Renard-Oldrini S, Ray-Coquard I, Liem X, Chevreau C, Lagrange JL, Mahé MA, Collin F, Bonnetain F, Bertaut A, Maingon P

EBioMedicine. 2019 Feb 28;:

Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging.

Laprie A, Ken S, Filleron T, Lubrano V, Vieillevigne L, Tensaouti F, Catalaa I, Boetto S, Khalifa J, Attal J, Peyraga G, Gomez-Roca C, Uro-Coste E, Noel G, Truc G, Sunyach MP, Magné N, Charissoux M, Supiot S, Bernier V, Mounier M, Poublanc M, Fabre A, Delord JP, Cohen-Jonathan Moyal E

BMC Cancer. 2019 Feb 21;19(1):167

Limbs and trunk soft tissue sarcoma systematic local and remote monitoring by MRI and thoraco-abdomino-pelvic scanner: A single-centre retrospective study.

De Angelis F, Guy F, Méjean N, Varbedian O, Bertaut A, Isambert N, Hervieu A, Truc G, Thibouw D, Barra CC, Fraisse J, Burnier P, Causeret S

Eur J Surg Oncol. 2019 Feb 5;:

Pediatric Localized Intracranial Ependymomas: A Multicenter Analysis of the Société Française de lutte contre les Cancers de l'Enfant (SFCE) from 2000 to 2013.

Ducassou A, Padovani L, Chaltiel L, Bolle S, Habrand JL, Claude L, Carrie C, Muracciole X, Coche-Dequeant B, Alapetite C, Supiot S, Demoor-Goldschmidt C, Bernier-Chastagner V, Huchet A, Leseur J, Le Prise E, Kerr C, Truc G, Nguyen TD, Bertozzi AI, Frappaz D, Boetto S, Sevely A, Tensaouti F, Laprie A,

Int. J. Radiat. Oncol. Biol. Phys.. 2018 Sep 1;102(1):166-173

Salvage brachytherapy as a modern reirradiation technique for local cancer failure: The Phoenix is reborn from its ashes.

Quivrin M, Peignaux-Casasnovas K, Martin É, Rouffiac M, Thibouw D, Chevalier C, Vulquin N, Aubignac L, Truc G, Créhange G

Cancer Radiother. 2018 May 30;:

Clinical and dosimetric study of radiotherapy for glioblastoma: three-dimensional conformal radiotherapy versus intensity-modulated radiotherapy.

Thibouw D, Truc G, Bertaut A, Chevalier C, Aubignac L, Mirjolet C

J. Neurooncol.. 2018 Apr;137(2):429-438

Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.

Reynaud T, Bertaut A, Farah W, Thibouw D, Crehange G, Truc G, Vulquin N

Technol. Cancer Res. Treat.. 2018 Jan 1;17:1533033818806498

Safety and efficacy of intensity-modulated radiotherapy in the management of spermatic cord sarcoma.

Cerda T, Martin É, Truc G, Créhange G, Maingon P

Cancer Radiother. 2017 Feb;21(1):16-20

Impact of waiting time on nodal staging in head and neck squamous-cell carcinoma treated with radical intensity modulated radiotherapy.

Chevalier C, Bertaut A, Quivrin M, Vulquin N, Desandes C, Folia M, Duvillard C, Truc G, Crehange G, Maingon P

Clin Transl Radiat Oncol. 2016 Dec;1:27-32

Identification of a candidate biomarker from perfusion MRI to anticipate glioblastoma progression after chemoradiation.

Khalifa J, Tensaouti F, Chaltiel L, Lotterie JA, Catalaa I, Sunyach MP, Ibarrola D, Noël G, Truc G, Walker P, Magné N, Charissoux M, Ken S, Peran P, Berry I, Moyal EC, Laprie A

Eur Radiol. 2016 Nov;26(11):4194-4203

Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?

Khalifa J, Tensaouti F, Lotterie JA, Catalaa I, Chaltiel L, Benouaich-Amiel A, Gomez-Roca C, Noël G, Truc G, Péran P, Berry I, Sunyach MP, Charissoux M, Johnson C, Cohen-Jonathan Moyal E, Laprie A

J. Neurooncol.. 2016 Oct;130(1):181-192

[Guidelines for the radiotherapy of gliomas].

Feuvret L, Antoni D, Biau J, Truc G, Noël G, Mazeron JJ

Cancer Radiother. 2016 Sep;20 Suppl:S69-79

[Radiotherapy for brain metastases].

Latorzeff I, Antoni D, Gaudaire-Josset S, Feuvret L, Tallet-Richard A, Truc G, Noël G

Cancer Radiother. 2016 Sep;20 Suppl:S80-7

Prognostic and therapeutic factors of gliosarcoma from a multi-institutional series.

Castelli J, Feuvret L, Haoming QC, Biau J, Jouglar E, Berger A, Truc G, Gutierrez FL, Morandi X, Le Reste PJ, Thillays F, Loussouarn D, Nouhaud E, Crehange G, Antoni D, Vauleon E, de Crevoisier R, Noel G

J. Neurooncol.. 2016 Aug;129(1):85-92

[French organization of paediatric radiation treatment: Results of a survey conducted by the radiotherapy Committee of the French Society of Paediatric Cancers (SFCE)].

Demoor-Goldschmidt C, Claude L, Carrie C, Bolle S, Helfre S, Alapetite C, Jouin A, Padovani L, Ducassou A, Vigneron C, Le Prisé É, Huchet A, Stefan D, Kerr C, Nguyen TD, Truc G, Chapet S, Bondiau PY, Coche B, Muracciole X, Laprie A, Noël G, Leseur J, Habrand JL, Potet H, Ruffier A, Supiot S, Mahé MA, Bernier V

Cancer Radiother. 2016 Jul;20(5):395-9

A phase I dose escalation study using simultaneous integrated-boost IMRT with temozolomide in patients with unifocal glioblastoma.

Truc G, Bernier V, Mirjolet C, Dalban C, Mazoyer F, Bonnetain F, Blanchard N, Lagneau É, Maingon P, Noël G

Cancer Radiother. 2016 May;20(3):193-8

[Whole brain radiation therapy for brain metastases: Advantages and controversies].

Noel G, Tallet A, Truc G, Bernier V, Feuvret L, Assouline A, Antoni D, Verrelle P, Mazeron JJ, Mornex F, Dhermain F

Cancer Radiother. 2015 Feb;19(1):30-5

[Locoregional treatments of brain metastases for patients with metastatic cutaneous melanoma: French national guidelines].

Lubrano V, Derrey S, Truc G, Mirabel X, Thariat J, Cupissol D, Sassolas B, Combemale P, Modiano P, Bedane C, Dygai-Cochet I, Lamant L, Mourregot A, Rouge Bugat ME, Siegrist S, Tiffet O, Mazeau-Woynar V, Verdoni L, Planchamp F, Leccia MT

Neurochirurgie. 2014 Dec;60(6):269-75

[Radiological evaluation of the tumour response after lung stereotactic radiotherapy].

Vulquin N, Feutray S, Peignaux-Casasnovas K, Humbert O, Crehange G, Truc G, Maingon P, Martin E

Cancer Radiother. 2014 Oct;18(5-6):414-9

Image-guided IMRT for localized prostate cancer with daily repositioning: inferring the difference between planned dose and delivered dose distribution.

Arnaud A, Maingon P, Gauthier M, Naudy S, Dumas JL, Martin E, Peignaux-Casasnovas K, Truc G, Bonnetain F, Crehange G

Phys Med. 2014 Sep;30(6):669-75

An international phase 3 trial in head and neck cancer: quality of life and symptom results: EORTC 24954 on behalf of the EORTC Head and Neck and the EORTC Radiation Oncology Group.

Bottomley A, Tridello G, Coens C, Rolland F, Tesselaar ME, Leemans CR, Hupperets P, Licitra L, Vermorken JB, Van Den Weyngaert D, Truc G, Barillot I, Lefebvre JL

Cancer. 2014 Feb 1;120(3):390-8

First-line and second-line systemic treatments of patients with metastatic cutaneous melanoma (without brain metastasis) : French national guidelines.

Cupissol D, Sassolas B, Combemale P, Modiano P, Bedane C, Derrey S, Dygai-Cochet I, Lamant L, Lubrano V, Mirabel X, Mourregot A, Bugat MER, Siegrist S, Thariat J, Tiffet O, Truc G, Verdoni L, Mazeau-Woynar V, Planchamp F, Leccia MT

Oncologie. 2014 Feb;16(2-3):137-47.

[Loco-regional treatments of the metastatic sites for patients with pauci-metastatic cutaneous melanoma (without brain metastasis): French national guidelines].

Sassolas B, Mourregot A, Thariat J, Tiffet O, Dygai-Cochet I, Mirabel X, Truc G, Cupissol D, Modiano P, Combemale P, Bedane C, Derrey S, Lamant L, Lubrano V, Siegrist S, Rouge-Bugat ME, Mazeau-Woynar V, Verdoni L, Planchamp F, Leccia MT

Bull Cancer. 2014 Jan 1;101(1):9-16

[The role of whole brain radiotherapy with hippocampal-sparing].

Truc G, Martin E, Mirjolet C, Chamois J, Petitfils A, Crehange G

Cancer Radiother. 2013 Oct;17(5-6):419-23

The radiosensitization effect of titanate nanotubes as a new tool in radiation therapy for glioblastoma: a proof-of-concept.

Mirjolet C, Papa AL, Crehange G, Raguin O, Seignez C, Paul C, Truc G, Maingon P, Millot N

Radiother Oncol. 2013 Jul;108(1):136-42

Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy.

Noel G, Huchet A, Feuvret L, Maire JP, Verrelle P, Le Rhun E, Aumont M, Thillays F, Sunyach MP, Henzen C, Missohou F, de Crevoisier R, Bondiau PY, Collin P, Durando X, Truc G, Kerr C, Bernier V, Clavier JB, Atlani D, D'Hombres A, Vinchon-Petit S, Lagrange JL, Taillandier L

J Neurooncol. 2012 Aug;109(1):167-75

Clinical impact of margin reduction on late toxicity and short-term biochemical control for patients treated with daily on-line image guided IMRT for prostate cancer.

Crehange G, Mirjolet C, Gauthier M, Martin E, Truc G, Peignaux-Casasnovas K, Azelie C, Bonnetain F, Naudy S, Maingon P

Radiother Oncol. 2012 May;103(2):244-6

Exclusive image-guided IMRT versus radical prostatectomy followed by postoperative IMRT for localized prostate cancer: A matched-pair analysis based on risk groups.

Azelie C, Gauthier M, Mirjolet-Didelot C, Cormier L, Martin E, Peignaux-Casasnovas K, Truc G, Maingon P, Crehange G

J. Clin. Oncol.. 2012 Feb;30(5_suppl):135

Exclusive image guided IMRT vs. radical prostatectomy followed by postoperative IMRT for localized prostate cancer: a matched-pair analysis based on risk-groups.

Azelie C, Gauthier M, Mirjolet C, Cormier L, Martin E, Peignaux-Casasnovas K, Truc G, Chamois J, Maingon P, Crehange G

Radiat Oncol. 2012 Sep 17;7:158

Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary.

Ligey A, Gentil J, Crehange G, Montbarbon X, Pommier P, Peignaux K, Truc G, Maingon P

Radiother Oncol. 2009 Dec;93(3):483-7

[Total skin electron beam therapy for early-stage mycosis fungoides: immediate results and long-term follow-up in 68 patients]

Goujon E, Truc G, Petrella T, Maingon P, Jeudy G, Collet E, Galliot C, Dalac-Rat S

Ann Dermatol Venereol. 2009 Mar;136(3):249-55

Pr TRUC Gilles

Fiche personne

coordonnées

Territoire

Statut

affiliation

équipes/plateformes

Recherche

Projets

Publications